SI
BCAB

Sofinnova Investments’s BIOATLA INC BCAB Stock Holding History

Sofinnova Investments’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-60
Closed -$102K – 68
2020
Q4 		$102K Buy
+60
New +$100K 0.01% 68

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sofinnova Investments's BCAB Position: Q1 2021 in Review

Sofinnova Investments sold out of BIOATLA INC (BCAB) in Q1 2021, closing a stake of 60 shares — an estimated $102K sold.

Sofinnova Investments first reported a position in BCAB in Q4 2020 and held it in 1 quarter. The position peaked at $102K in Q4 2020. 62 funds tracked by Wall St. Rank hold BCAB as of Q1 2021.

  • Sofinnova Investments reported no remaining BIOATLA INC position as of Q1 2021 after selling out during the quarter.
  • Sofinnova Investments sold 60 BIOATLA INC shares in Q1 2021, an estimated $102K.
  • Sofinnova Investments first reported a position in BIOATLA INC in Q4 2020 and held it in 1 quarter.
  • Sofinnova Investments's BIOATLA INC position peaked at $102K in Q4 2020.
  • 62 funds tracked by Wall St. Rank held BIOATLA INC as of Q1 2021.

Based on Sofinnova Investments's 13F filing for Q1 2021, filed 14 May 2021.